Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H26N2O.ClH |
| Molecular Weight | 358.905 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NC(=O)C(CCN1CCCCC1)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=GNQVMBPLQIGMHJ-UHFFFAOYSA-N
InChI=1S/C21H26N2O.ClH/c22-20(24)21(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-23-15-8-3-9-16-23;/h1-2,4-7,10-13H,3,8-9,14-17H2,(H2,22,24);1H
| Molecular Formula | C21H26N2O |
| Molecular Weight | 322.4439 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cardiovascular effects of a proprietary l-methadone/fenpipramide combination (Polamivet) alone and in addition to acepromazine in healthy Beagle dogs. | 2012-09 |
|
| Repeated anaesthesia with isoflurane and xylazine/levomethadone/fenpipramide premedication in female Beagle dogs: influence on general health and wellbeing. | 2008-10 |
|
| Nifedipine in the treatment of renal colic. | 1986-09 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:28:57 GMT 2025
by
admin
on
Mon Mar 31 18:28:57 GMT 2025
|
| Record UNII |
KJ2V75P034
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Mon Mar 31 18:28:57 GMT 2025 , Edited by admin on Mon Mar 31 18:28:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20161223
Created by
admin on Mon Mar 31 18:28:57 GMT 2025 , Edited by admin on Mon Mar 31 18:28:57 GMT 2025
|
PRIMARY | |||
|
C78073
Created by
admin on Mon Mar 31 18:28:57 GMT 2025 , Edited by admin on Mon Mar 31 18:28:57 GMT 2025
|
PRIMARY | |||
|
SUB02123MIG
Created by
admin on Mon Mar 31 18:28:57 GMT 2025 , Edited by admin on Mon Mar 31 18:28:57 GMT 2025
|
PRIMARY | |||
|
100000086964
Created by
admin on Mon Mar 31 18:28:57 GMT 2025 , Edited by admin on Mon Mar 31 18:28:57 GMT 2025
|
PRIMARY | |||
|
237-816-3
Created by
admin on Mon Mar 31 18:28:57 GMT 2025 , Edited by admin on Mon Mar 31 18:28:57 GMT 2025
|
PRIMARY | |||
|
KJ2V75P034
Created by
admin on Mon Mar 31 18:28:57 GMT 2025 , Edited by admin on Mon Mar 31 18:28:57 GMT 2025
|
PRIMARY | |||
|
166974
Created by
admin on Mon Mar 31 18:28:57 GMT 2025 , Edited by admin on Mon Mar 31 18:28:57 GMT 2025
|
PRIMARY | |||
|
14007-53-5
Created by
admin on Mon Mar 31 18:28:57 GMT 2025 , Edited by admin on Mon Mar 31 18:28:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |